Select Equity Group’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$580M Buy
2,174,785
+64,006
+3% +$17.3M 2.97% 9
2025
Q4
$530M Buy
2,110,779
+273,744
+15% +$72.7M 2.28% 14
2025
Q3
$527M Sell
1,837,035
-295,757
-14% -$79.2M 2.17% 17
2025
Q2
$560M Sell
2,132,792
-87,264
-4% -$21.2M 2.35% 18
2025
Q1
$517M Buy
2,220,056
+624,099
+39% +$151M 2.23% 16
2024
Q4
$366M Buy
1,595,957
+959,981
+151% +$220M 1.45% 28
2024
Q3
$142M Buy
635,976
+272,711
+75% +$59.9M 0.51% 53
2024
Q2
$73.9M Buy
+363,265
New +$73.9M 0.29% 66

Other funds holding LH

Select Equity Group's LH Position: Q1 2026 in Review

Select Equity Group increased its Labcorp (LH) stake by 3% in Q1 2026, buying an estimated $17.3M and bringing the position to 2,174,785 shares worth $580M. The position accounts for 2.97% of the portfolio, ranked #9.

Select Equity Group first reported a position in LH in Q2 2024 and has held it in 8 quarters since. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Select Equity Group held 2,174,785 shares of Labcorp worth $580M as of Q1 2026.
  • Select Equity Group bought 64,006 Labcorp shares in Q1 2026, an estimated $17.3M.
  • Labcorp made up 2.97% of Select Equity Group's portfolio in Q1 2026, its #9 holding.
  • Select Equity Group first reported a position in Labcorp in Q2 2024 and has held it in 8 quarters since.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Select Equity Group's 13F filing for Q1 2026, filed 15 May 2026.